Hong Kong Stock Movement | Changfeng Pharmaceutical (02652.HK) rises over 5% after completing the placement of 21.7477 million new H shares. ICF001 is expected to fill the clinical gap in the treatment of PH-ILD.

Zhiyitong Finance APP has learned that Changfeng Pharmaceutical (02652.HK) has risen over 5%. As of the time of writing, it has increased by 4.84%, trading at HKD 16.89, with a transaction volume of HKD 65.3977 million.